1.Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018. DOI: 10.1016/S0140–6736(18)30010–2
2.Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China. Cancer letters 2018; 412: 283–288. DOI: 10.1016/j.canlet.2017.10.008
3.Zhu H, Wu J, Shen X. Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes. Scandinavian journal of gastroenterology 2017; 52: 209–215. DOI: 10.1080/00365521.2016.1245778
4.Sudhagar A, Kumar G, El-Matbouli M. Transcriptome Analysis Based on RNA-Seq in Understanding Pathogenic Mechanisms of Diseases and the Immune System of Fish: A Comprehensive Review. International journal of molecular sciences 2018; 19. DOI: 10.3390/ijms19010245
5.Milan T, Wilhelm BT. Mining Cancer Transcriptomes: Bioinformatic Tools and the Remaining Challenges. Molecular diagnosis & therapy 2017; 21: 249–258. DOI: 10.1007/s40291–017–0264–1
6.McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiological reviews 2010; 90: 1337–1381. DOI: 10.1152/physrev.00058.2009
7.Kim CK, He P, Bialkowska AB, Yang VW. SP and KLF Transcription Factors in Digestive Physiology and Diseases. Gastroenterology 2017; 152: 1845–1875. DOI: 10.1053/j.gastro.2017.03.035
8.Cao Z, Sun X, Icli B, Wara AK, Feinberg MW. Role of Kruppel-like factors in leukocyte development, function, and disease. Blood 2010; 116: 4404–4414. DOI: 10.1182/blood–2010–05–285353
9.Lu XJ, Shi Y, Chen JL, Ma S. Kruppel-like factors in hepatocellular carcinoma. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 2015; 36: 533–541. DOI: 10.1007/s13277–015–3127–6
10.Li JC, Yang XR, Sun HX, Xu Y, Zhou J, Qiu SJ, Ke AW, Cui YH, Wang ZJ, Wang WM, Liu KD, Fan J. Up-regulation of Kruppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma. Gastroenterology 2010; 139: 2146–2157 e2112. DOI: 10.1053/j.gastro.2010.08.004
11.Yang T, Cai SY, Zhang J, Lu JH, Lin C, Zhai J, Wu MC, Shen F. Kruppel-like factor 8 is a new Wnt/beta-catenin signaling target gene and regulator in hepatocellular carcinoma. PloS one 2012; 7: e39668. DOI: 10.1371/journal.pone.0039668
12.van Vliet J, Turner J, Crossley M. Human Kruppel-like factor 8: a CACCC-box binding protein that associates with CtBP and represses transcription. Nucleic acids research 2000; 28: 1955–1962.
13.Zhao J, Bian ZC, Yee K, Chen BP, Chien S, Guan JL. Identification of transcription factor KLF8 as a downstream target of focal adhesion kinase in its regulation of cyclin D1 and cell cycle progression. Molecular cell 2003; 11: 1503–1515.
14.Wang X, Zheng M, Liu G, Xia W, McKeown-Longo PJ, Hung MC, Zhao J. Kruppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer research 2007; 67: 7184–7193. DOI: 10.1158/0008–5472.CAN–06–4729
15.Lahiri SK, Zhao J. Kruppel-like factor 8 emerges as an important regulator of cancer. American journal of translational research 2012; 4: 357–363.
16.Cho SW, Kim S, Kim JM, Kim JS. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nature biotechnology 2013; 31: 230–232. DOI: 10.1038/nbt.2507
17.Turner BM. Histone acetylation and control of gene expression. Journal of cell science 1991; 99 ( Pt 1): 13–20.
18.Smith E, Shilatifard A. Enhancer biology and enhanceropathies. Nature structural & molecular biology 2014; 21: 210–219. DOI: 10.1038/nsmb.2784
19.Chen Y, Jorgensen M, Kolde R, Zhao X, Parker B, Valen E, Wen J, Sandelin A. Prediction of RNA Polymerase II recruitment, elongation and stalling from histone modification data. BMC genomics 2011; 12: 544. DOI: 10.1186/1471–2164–12–544
20.Roe JS, Hwang CI, Somerville TDD, Milazzo JP, Lee EJ, Da Silva B, Maiorino L, Tiriac H, Young CM, Miyabayashi K, Filippini D, Creighton B, Burkhart RA, Buscaglia JM, Kim EJ, Grem JL, Lazenby AJ, Grunkemeyer JA, Hollingsworth MA, Grandgenett PM, Egeblad M, Park Y, Tuveson DA, Vakoc CR. Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis. Cell 2017; 170: 875–888 e820. DOI: 10.1016/j.cell.2017.07.007
21.Wang S, Sun H, Ma J, Zang C, Wang C, Wang J, Tang Q, Meyer CA, Zhang Y, Liu XS. Target analysis by integration of transcriptome and ChIP-seq data with BETA. Nature protocols 2013; 8: 2502–2515. DOI: 10.1038/nprot.2013.150
22.Fedele M, Palmieri D, Fusco A. HMGA2: A pituitary tumour subtype-specific oncogene? Molecular and cellular endocrinology 2010; 326: 19–24. DOI: 10.1016/j.mce.2010.03.019
23.Kaur H, Ali SZ, Huey L, Hutt-Cabezas M, Taylor I, Mao XG, Weingart M, Chu Q, Rodriguez FJ, Eberhart CG, Raabe EH. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma. Cancer letters 2016; 377: 55–64. DOI: 10.1016/j.canlet.2016.04.020
24.Wu J, Zhang S, Shan J, Hu Z, Liu X, Chen L, Ren X, Yao L, Sheng H, Li L, Ann D, Yen Y, Wang J, Wang X. Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer. Cancer letters 2016; 376: 284–292. DOI: 10.1016/j.canlet.2016.04.005
25.Poulaki V, Mitsiades CS, Mitsiades N. The role of Fas and FasL as mediators of anticancer chemotherapy. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 2001; 4: 233–242. DOI: 10.1054/drup.2001.0210
26.Williams H, Johnson JL, Jackson CL, White SJ, George SJ. MMP–7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis. Cardiovascular research 2010; 87: 137–146. DOI: 10.1093/cvr/cvq042
27.Lu H, Wang X, Li T, Urvalek AM, Yu L, Li J, Zhu J, Lin Q, Peng X, Zhao J. Identification of poly (ADP-ribose) polymerase–1 (PARP–1) as a novel Kruppel-like factor 8-interacting and -regulating protein. The Journal of biological chemistry 2011; 286: 20335–20344. DOI: 10.1074/jbc.M110.215632
28.Cleynen I, Van de Ven WJ. The HMGA proteins: a myriad of functions (Review). International journal of oncology 2008; 32: 289–305.
29.Reeves R. High mobility group (HMG) proteins: Modulators of chromatin structure and DNA repair in mammalian cells. DNA repair 2015; 36: 122–136. DOI: 10.1016/j.dnarep.2015.09.015
30.Fujikane R, Komori K, Sekiguchi M, Hidaka M. Function of high-mobility group A proteins in the DNA damage signaling for the induction of apoptosis. Scientific reports 2016; 6: 31714. DOI: 10.1038/srep31714
31.Gao X, Dai M, Li Q, Wang Z, Lu Y, Song Z. HMGA2 regulates lung cancer proliferation and metastasis. Thoracic cancer 2017; 8: 501–510. DOI: 10.1111/1759–7714.12476
32.Esmailzadeh S, Mansoori B, Mohammadi A, Shanehbandi D, Baradaran B. siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma. Journal of gastrointestinal cancer 2017; 48: 156–163. DOI: 10.1007/s12029–016–9871-z
33.Zhang H, Tang Z, Deng C, He Y, Wu F, Liu O, Hu C. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma. Oral diseases 2017; 23: 255–264. DOI: 10.1111/odi.12608
34.Cai J, Shen G, Liu S, Meng Q. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 2016; 37: 699–707. DOI: 10.1007/s13277–015–3853–9
35.Huang W, Li J, Guo X, Zhao Y, Yuan X. miR–663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2016; 81: 431–438. DOI: 10.1016/j.biopha.2016.04.034
36.Ou W, Lv J, Zou X, Yao Y, Wu J, Yang J, Wang Z, Ma Y. Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/beta-catenin pathway. Experimental and therapeutic medicine 2017; 13: 2501–2506. DOI: 10.3892/etm.2017.4253
37.Wang Y, Chen F, Zhao M, Yang Z, Li J, Zhang S, Zhang W, Ye L, Zhang X. The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA–186. The Journal of biological chemistry 2017; 292: 15395–15407. DOI: 10.1074/jbc.M117.783738
38.Zhang W, Li Y, Yang L, Zhou B, Chen KL, Meng WJ, Liu Y, Hu JK, Sun XF, Zhou ZG. Knockdown of MMP–7 inhibits cell proliferation and enhances sensitivity to 5-Fluorouracil and X-ray irradiation in colon cancer cells. Clinical and experimental medicine 2014; 14: 99–106. DOI: 10.1007/s10238–012–0212–7